Clinical Trial Update: Clopidogrel for the Prevention of Exacerbations in Severe COPD [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating clopidogrel for preventing exacerbations in severe COPD, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COPD Exacerbation
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Lady Reading Hospital, Pakistan | Conditions: COPD, COPD Exacerbation Acute | Phase 3 | Status: UNKNOWN